Chitosan: an update on potential biomedical and pharmaceutical applications

RCF Cheung, TB Ng, JH Wong, WY Chan - Marine drugs, 2015 - mdpi.com
Chitosan is a natural polycationic linear polysaccharide derived from chitin. The low
solubility of chitosan in neutral and alkaline solution limits its application. Nevertheless …

Chitosan as excellent bio-macromolecule with myriad of anti-activities in biomedical applications–A review

S Jagdale, B Agarwal, A Dixit, S Gaware - International Journal of …, 2024 - Elsevier
The aim of the study is to explore the myriad of anti-activities of chitosan-deacylated
derivative of chitin in biomedical applications. Chitosan consists of reactive residual amino …

Lipid nanoparticles as promising carriers for mRNA vaccines for viral lung infections

M Hajiaghapour Asr, F Dayani, F Saedi Segherloo… - Pharmaceutics, 2023 - mdpi.com
In recent years, there has been an increase in deaths due to infectious diseases, most
notably in the context of viral respiratory pathogens. Consequently, the focus has shifted in …

[HTML][HTML] Anti-CD4 antibody and dendrimeric peptide based targeted nano-liposomal dual drug formulation for the treatment of HIV infection

SP Mutalik, SY Gaikwad, G Fernandes, A More… - Life Sciences, 2023 - Elsevier
Aims Development and characterization of LAM and DTG loaded liposomes conjugated anti-
CD4 antibody and peptide dendrimer (PD2) to improve the therapeutic efficacy and to …

Applications of Fourier transform infrared spectroscopy to pharmaceutical preparations

Y Song, Y Cong, B Wang, N Zhang - Expert opinion on drug …, 2020 - Taylor & Francis
Introduction: Various pharmaceutical preparations are widely used for clinical treatment.
Elucidation of the mechanisms of drug release and evaluation of drug efficacy in biological …

Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems

F Hejabi, MS Abbaszadeh, S Taji, A O'Neill… - Frontiers in …, 2022 - frontiersin.org
In recent decades, clustered regularly interspaced short palindromic repeat/CRISPR-
associated protein (CRISPR/Cas) has become one of the most promising genome-editing …

A clinical perspective of chitosan nanoparticles for infectious disease management

F Dilnawaz, S Acharya, A Kanungo - Polymer Bulletin, 2024 - Springer
Infectious diseases and their effective management are still a challenge in this modern era
of medicine. Diseases, such as the SARS-CoV-2, Ebola virus, and Zika virus, still put human …

Nanoparticle-based strategies to target HIV-infected cells

D Soundararajan, LN Ramana, P Shankaran… - Colloids and Surfaces B …, 2022 - Elsevier
Antiretroviral drugs employed for the treatment of human immunodeficiency virus (HIV)
infections have remained largely ineffective due to their poor bioavailability, numerous …

Virus-host interactions: new insights and advances in drug development against viral pathogens

M Prasad, K Ranjan, B Brar, I Shah… - Current Drug …, 2017 - ingentaconnect.com
Background: Viruses are the most devastating pathogens of almost all life forms including
humans and animals. Viruses can replicate very fast and may affect any metabolic and …

Lamivudine‐conjugated and efavirenz‐loaded G2 dendrimers: Novel anti‐retroviral nano drug delivery systems

EM Pargoo, MR Aghasadeghi, K Parivar… - IET …, 2021 - Wiley Online Library
Infection with human immunodeficiency virus (HIV)‐1 causes immunological disorders and
death worldwide which needs to be further assisted by novel anti‐retroviral drug delivery …